Settings

saved!

stooonks

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.


AK Medical Holdings Limited

🇨🇳 China · HKEX: 1789.HK · Market cap: $1.2B

AK Medical makes artificial hip and knee joints and other orthopedic implants for hospitals in China.

AK Medical makes the parts that go inside your body when your own parts wear out. Its main products are artificial hip joints, knee joints, and spinal implants, mostly made of metal and special plastics. When someone's hip is so worn down that walking hurts, a surgeon cuts out the damaged bone and fits in one of these implants. The company sells mainly to hospitals across China, and those hospitals pay for the implants, often through the country's national health insurance system. Think of it as a replacement-parts shop, but for human skeletons.

The business grew fast because China's population is aging and more people can afford surgery. For years, foreign companies like Stryker and Zimmer Biomet dominated the premium end of the market, but AK Medical built a reputation for implants that cost less while still working well. That mix of decent quality and lower price let it win business from hospitals that were under pressure to control costs. The company also invests heavily in research, which matters because an implant has to survive inside a patient for fifteen or twenty years, so surgeons are cautious about switching brands.

The big recent story is a government policy. China ran a national bulk-buying program for hip and knee implants, where the government basically says: we will buy huge volumes, but you must cut your price hard. Prices fell dramatically, which hurt revenue per surgery, but the volume of surgeries went up because more patients could now afford the operation. So the company is betting that selling many more implants at thinner margins still works out fine. It has also been pushing into higher-end products like 3D-printed implants, which are custom-shaped to fit a specific patient's bones, and expanding sales of spinal products. How well it handles the price cuts while keeping quality high is the main thing to watch.

Saved answer · last researched 10 Oct 2026

CONTINUED